Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hepatitis C Virus Envelope Protein E2 - Overview
Hepatitis C Virus Envelope Protein E2 - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Hepatitis C Virus Envelope Protein E2 - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hepatitis C Virus Envelope Protein E2 - Companies Involved in Therapeutics Development
Enid Therapeutics LLC
Integrated BioTherapeutics Inc
Toray Industries Inc
Hepatitis C Virus Envelope Protein E2 - Drug Profiles
CIGB-230 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C (strain H77) vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
hepatitis C vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibodies to Inhibit E2 Glycoprotein for HCV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibodies to Target Viral E1 and E2 Proteins for Hepatitis C - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclol Antibody to Inhibit E1 and E2 Glycoprotein for Hepatitis C - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides to Inhibit E1 and E2 Glycoprotein for HCV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hepatitis C Virus Envelope Protein E2 - Dormant Products
Hepatitis C Virus Envelope Protein E2 - Discontinued Products
Hepatitis C Virus Envelope Protein E2 - Product Development Milestones
Featured News & Press Releases
Jun 10, 2013: IBT and Stanford Awarded STTR
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development by Stage of Development, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020


List of Tables


Number of Products under Development by Stage of Development, H2 2020
Number of Products under Development by Therapy Areas, H2 2020
Number of Products under Development by Indication, H2 2020
Number of Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020
Number of Products under Investigation by Universities/Institutes, H2 2020
Products under Investigation by Universities/Institutes, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Pipeline by Ennaid Therapeutics LLC, H2 2020
Pipeline by Integrated BioTherapeutics Inc, H2 2020
Pipeline by Toray Industries Inc, H2 2020
Dormant Projects, H2 2020
Discontinued Products, H2 2020